Cardio Diagnostics (CDIO) to Release Quarterly Earnings on Monday

Cardio Diagnostics (NASDAQ:CDIO) is expected to announce its earnings results before the market opens on Monday, April 7th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $0.03 million for the quarter.

Cardio Diagnostics Stock Performance

Cardio Diagnostics stock opened at $0.38 on Monday. Cardio Diagnostics has a twelve month low of $0.19 and a twelve month high of $1.77. The stock’s 50 day moving average is $0.48 and its 200 day moving average is $0.48.

About Cardio Diagnostics

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease.